Andrew J. Holman

Dr. Holman is the founding rheumatologist at Pacific Rheumatology Associates Inc PS, Director of Research at Pacific Rheumatology Research Inc., a former President of the Northwest Rheumatism Society (2005) and a Clinical Associate Professor of Medicine at the University of Washington. He has 25 year clinical and 19 year rheumatology research career experience with 16 lead author published papers, 25 lead author published abstracts. For Inmedix, he has designed, completed and published 15 clinical studies, including FDA negotiations, involving nearly 1500 patients.

Research highlights include discovering and licensing use of dopamine agonists as a treatment of fibromyalgia, applying autonomic nervous system (ANS) analysis with heart rate variability (HRV) to elevate treatment remission rates in patients with rheumatoid arthritis and other autoimmune diseases, and broadening understanding of pain in patients with PC3 (positional cervical cord compression) using dynamic cervical magnetic resonance imaging (dMRI).